Bruker winds down underperforming instrument lines


Instrument heavyweight Bruker is winding down its range of stand-alone gas chromatography (GC), inductively-coupled plasma mass spectrometry (ICP-MS) and single quadrupole GC-MS instruments. In a statement, the company said that its Chemical and Applied Markets division, which houses these products, has generated significant losses for the last four years, with little prospect of near-term profitability.

Bruker will honour outstanding orders for the affected GC and GC-MS instruments, but is not taking any new orders. The company is looking to sell off its ICP-MS business, and for someone to take over the service contracts for the GC instruments. The firm will retain support for GC-MS systems, as it continues to sell instruments with triple-quadrupole mass detectors.

At the same time, the company is expanding its microscopy offering in the life sciences, by acquiring US start-up Vutara for its high speed, 3D, super resolution fluorescence microscopy technology. The companies did not disclose financial details of the transaction.


Related Content

A close look at microscopy

5 November 2013 Review

news image

Elisabeth Jeffries zooms in on scanning probe microscopy and other techniques

Company Profile: Analytical technology worldwide

27 August 2010 Jobs Profile (Company)

news image

Scientific instrument manufacturer Bruker has come a long way in 50 years, discovers Matt Brown

Most Read

Quintuple bond activates small stable molecules

19 September 2014 Research

news image

Exotic complexes suggest route to synthetic feedstock

Computer simulations point to formamide as prebiotic intermediate in ‘Miller’ mixtures

16 September 2014 News and Analysis

news image

Electric field may have provided more than just energy for primordial chemistry

Most Commented

Painkiller found in plants may not be natural after all

18 September 2014 Research

news image

Cow pats from cattle fed tramadol could explain how the drug came to be in an African herb

US genomics lead being lost to China

17 September 2014 News and Analysis

news image

NIH senior leaders are sounding the alarm bells, saying the US's pre-eminence in genomics research is under threat